Clinical Study

Does Early Graft Patency Benefit from Perioperative Statin Therapy? A Propensity Score-Matched Study of Patients Undergoing Off-Pump Coronary Artery Bypass Surgery

Table 1

Baseline and graft characteristics of overall patient before IPW Adjustment.

Patient baseline and
graft characteristics
CS groupDS groupP-Value
(n=398)(n=184)

Age, years62.160.20.038
 ≤60yr, %40.549.50.042
 >60yr, %59.550.50.042
Female, %22.918.50.230
BMI, kg/m225.326.00.007
Current smoking, %50.853.30.570
Diabetes mellitus, %37.934.80.460
Hypertension, %72.460.90.005
Dyslipidemia, %68.858.50.014
Acute coronary syndrome, %72.166.30.160
Left main disease, %38.439.10.870
Triple vessel disease, %86.785.30.660
Previous PCI, %16.88.20.002
Previous MI, %36.729.90.110
Stroke or TIA, %11.69.20.400
LVEF, %60.359.80.540
LDL-C, mg/dL96.6793.970.410
TC, mmol/L4.354.190.090
Creatinine, mg/dL0.940.940.850
GFR, mL/min/1.73m282.2784.580.120
ALT, U/L29.1736.510.004
AST, U/L22.0823.630.170
Medication
 Aspirin, %64.178.8<0.001
 Beta-blocker, %88.787.00.550
 ACEI or ARB, %48.021.2<0.001
Distal anastomoses (mean distal)1275 (3.2)595 (3.2)0.683
 Total graft12155610.952
  SVG8313780.614
  Arterial graft3841830.130
 Sequential bypass anastomoses60340.312

IPW = inverse probability weighting; CS = perioperative continuation of statin therapy; DS = discontinuous statin therapy; IHD = ischemic heart disease; PCI = percutaneous coronary intervention; MI = myocardial infarction; TIA = transient ischemic attack; LVEF = left ventricular ejection fraction; LDL-C = low-density lipoprotein cholesterol; TC = total cholesterol; GFR = glomerular filtration rate; ALT = alanine transaminase; AST = aspartate aminotransferase; ACEI = angiotensin-converting-enzyme inhibitor; ARB = angiotensin receptor blocker; SVG = saphenous vein graft.
†The glomerular filtration rate (GFR) was estimated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.